1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Failure of responsive regulation? Pharmaceutical marketing, corporate impression management and off-label promotion of enzalutamide in Europe (
- The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza (
- The importance of geographical distance to different types of R&D collaboration in the pharmaceutical industry (
- 2019
- Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK (
- 2018
- Drivers of pharmaceutical packaging innovation: a customer-supplier relationship case study (
- Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries (
- 2017
- Exploring pharmaceutical packaging innovation management: a customer-supplier relationship case study (
- 2015
- Divergence and convergence of commercial and scientific priorities in drug development: the case of Zelmid, the first SSRI antidepressant (
- Design process for innovation in pharmaceutical packaging: reviewing needs and modes of activity (
- 2009
- Design and testing of a small-scale sublimation apparatus (